Literature DB >> 21454194

Report from the Sixth International Workshop on Waldenström's Macroglobulinemia.

Steven P Treon1, Giampaolo Merlini, Enrica Morra, Christopher J Patterson, Marvin J Stone.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21454194     DOI： 10.3816/CLML.2011.n.010

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

1.  Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature.

Authors:  Kenichi Ito; Risa Nishiyama; Kazuhiko Hirano; Kazuaki Yamada; Naohiro Sekiguchi
Journal:  Blood Res       Date:  2019-09-25

2.  Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea.

Authors:  Ho Sup Lee; Kihyun Kim; Dok Hyun Yoon; Jin Seok Kim; Soo-Mee Bang; Jeong-Ok Lee; Hyeon Seok Eom; Hyewon Lee; Inho Kim; Won Sik Lee; Sung Hwa Bae; Se Hyung Kim; Mark Hong Lee; Young Rok Do; Jae Hoon Lee; Junshik Hong; Ho-Jin Shin; Ji Hyun Lee; Yeung-Chul Mun; Chang-Ki Min
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

3.  Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent.

Authors:  Naohiro Sekiguchi; Airi Hamano; Tomoko Kitagawa; Yuya Kurihara; Kenichi Ito; Miwa Kurimoto; Kozo Watanabe; Kazuhiko Hirano; Satoshi Noto; Kazuaki Yamada; Naoki Takezako
Journal:  Blood Res       Date:  2018-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.